|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 14/00 | (2006.01) | ||
| A61K 38/16 | (2006.01) | ||
| C07K 14/775 | (2006.01) | ||
| A61K 38/17 | (2006.01) |
| (11) | Number of the document | 2939683 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15157397.9 |
| Date of filing the European patent application | 2010-02-12 | |
| (97) | Date of publication of the European application | 2015-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-04 |
| (46) | Date of publication of the claims translation | 2017-03-27 |
| (30) | Number | Date | Country code |
| 152966 P | 2009-02-16 | US | |
| 152962 P | 2009-02-16 | US | |
| 152960 P | 2009-02-16 | US |
| (72) |
Dasseux, Jean-Louis, FR
Schwendeman, Anna Shenderova, US
Zhu, Lingyu, CN
|
| (73) |
Cerenis Therapeutics Holding SA,
265 Rue de la Découverte, 31670 Labege,
FR
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Apolipoproteino A-I mimetikai |
| Apolipoprotein A-I Mimics |
| Payment date | Validity (years) | Amount | |
| 2019-01-28 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-02-12 |